Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

VCYT – Veracyte, Inc.

Float Short %

11.81

Margin Of Safety %

-14

Put/Call OI Ratio

0.19

EPS Next Q Diff

0.06

EPS Last/This Y

1.11

EPS This/Next Y

0.01

Price

31

Target Price

41.22

Analyst Recom

1.55

Performance Q

13.14

Relative Volume

0.73

Beta

2.04

Ticker: VCYT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25VCYT25.260.450.04669
2025-07-28VCYT25.020.420.03716
2025-07-29VCYT24.50.370.90777
2025-07-30VCYT240.450.37862
2025-07-31VCYT23.530.430.00881
2025-08-01VCYT23.650.390.12956
2025-08-04VCYT24.320.370.05991
2025-08-05VCYT250.350.041030
2025-08-06VCYT23.970.330.551078
2025-08-07VCYT27.680.360.231249
2025-08-08VCYT27.380.380.001266
2025-08-11VCYT28.050.390.001242
2025-08-12VCYT28.770.210.642034
2025-08-13VCYT30.690.210.022060
2025-08-14VCYT30.040.220.242002
2025-08-15VCYT30.220.220.072008
2025-08-18VCYT30.060.190.501780
2025-08-19VCYT29.580.190.001760
2025-08-20VCYT29.490.190.001761
2025-08-21VCYT29.430.190.001740
2025-08-22VCYT31.020.190.001734
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25VCYT25.25-0.378.61.30
2025-07-28VCYT25.06-0.369.61.30
2025-07-29VCYT24.47-1.268.01.30
2025-07-30VCYT23.97-1.268.11.30
2025-07-31VCYT23.51-1.268.31.30
2025-08-01VCYT23.64-1.271.11.30
2025-08-04VCYT24.32-1.273.81.30
2025-08-05VCYT25.01-1.273.81.30
2025-08-06VCYT23.98-1.265.71.30
2025-08-07VCYT27.68-1.288.41.30
2025-08-08VCYT27.37-6.669.11.42
2025-08-11VCYT28.00-6.680.31.42
2025-08-12VCYT28.77-4.583.11.42
2025-08-13VCYT30.68-4.387.81.42
2025-08-14VCYT30.03-4.377.11.41
2025-08-15VCYT30.20-3.580.31.41
2025-08-18VCYT30.06-3.579.01.41
2025-08-19VCYT29.57-3.577.61.41
2025-08-20VCYT29.51-3.579.41.41
2025-08-21VCYT29.42-3.579.41.43
2025-08-22VCYT31.00-3.586.21.43
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25VCYT-2.11-2.207.92
2025-07-28VCYT-2.11-2.407.92
2025-07-29VCYT-2.15-2.407.92
2025-07-30VCYT-2.15-2.407.92
2025-07-31VCYT-2.15-2.407.92
2025-08-01VCYT-2.15-2.407.92
2025-08-04VCYT-2.15-2.367.92
2025-08-05VCYT-2.15-2.367.92
2025-08-06VCYT-2.11-2.367.92
2025-08-07VCYT-2.11-2.367.92
2025-08-08VCYT-2.11-2.367.92
2025-08-11VCYT-2.10-2.097.89
2025-08-12VCYT-2.10-2.0911.71
2025-08-13VCYT-2.10-2.0911.71
2025-08-14VCYT-2.10-2.0911.71
2025-08-15VCYT-2.10-2.0911.71
2025-08-18VCYT-2.106.9711.71
2025-08-19VCYT-2.106.9711.81
2025-08-20VCYT-1.386.9711.81
2025-08-21VCYT-1.386.9711.81
2025-08-22VCYT-1.386.9711.81
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.31

Avg. EPS Est. Current Quarter

0.32

Avg. EPS Est. Next Quarter

0.37

Insider Transactions

-1.38

Institutional Transactions

6.97

Beta

2.04

Average Sales Estimate Current Quarter

124

Average Sales Estimate Next Quarter

131

Fair Value

26.71

Quality Score

85

Growth Score

59

Sentiment Score

48

Actual DrawDown %

64

Max Drawdown 5-Year %

-81.2

Target Price

41.22

P/E

93.18

Forward P/E

21.31

PEG

1.27

P/S

5.09

P/B

2

P/Free Cash Flow

29.04

EPS

0.33

Average EPS Est. Cur. Y​

1.43

EPS Next Y. (Est.)

1.43

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.5

Relative Volume

0.73

Return on Equity vs Sector %

-22.5

Return on Equity vs Industry %

-8.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.13

EBIT Estimation

86.2
Veracyte, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 824
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
stock quote shares VCYT – Veracyte, Inc. Stock Price stock today
news today VCYT – Veracyte, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VCYT – Veracyte, Inc. yahoo finance google finance
stock history VCYT – Veracyte, Inc. invest stock market
stock prices VCYT premarket after hours
ticker VCYT fair value insiders trading